Literature DB >> 10560215

Risperidone in comorbid ADHD and ODD/CD.

G D Kewley.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10560215     DOI: 10.1097/00004583-199911000-00002

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


× No keyword cloud information.
  6 in total

Review 1.  The QT interval and psychotropic medications in children: recommendations for clinicians.

Authors:  Paul McNally; Fiona McNicholas; Paul Oslizlok
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-29       Impact factor: 4.785

2.  Risperidone treatment in 12 children with developmental disorders and attention-deficit/hyperactivity disorder.

Authors:  Valsamma Eapen; A K Gururaj
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

Review 3.  Antipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerability.

Authors:  David Linton; Alasdair M Barr; William G Honer; Ric M Procyshyn
Journal:  Curr Psychiatry Rep       Date:  2013-05       Impact factor: 5.285

Review 4.  Issues in the management of patients with complex attention-deficit hyperactivity disorder symptoms.

Authors:  Thomas J Spencer
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

5.  Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone.

Authors:  Christian Fleischhaker; Philip Heiser; Klaus Hennighausen; Beate Herpertz-Dahlmann; Kristian Holtkamp; Claudia Mehler-Wex; Reinhold Rauh; Helmut Remschmidt; Eberhard Schulz; Andreas Warnke
Journal:  J Neural Transm (Vienna)       Date:  2008-09-09       Impact factor: 3.575

6.  Treatment of the special patient with schizophrenia.

Authors:  R R Conley; D L Kelly
Journal:  Dialogues Clin Neurosci       Date:  2001-06       Impact factor: 5.986

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.